PROLONGED INFUSION OF GLUCAGON-LIKE PEPTIDE-1 IN TYPE-2 DIABETES NORMALIZES INSULIN-RESPONSE TO GLUCOSE

PROLONGED INFUSION OF GLUCAGON-LIKE PEPTIDE-1 IN TYPE-2 DIABETES NORMALIZES INSULIN-RESPONSE TO GLUCOSE

Bibliographic Details
Main Authors:	Gribble, F, Rachman, J, Levy, J, Barrow, B, Turner, R
Format:	Journal article
Published:	1995

Similar Items

Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.
by: Rachman, J, et al.
Published: (1996)

Near-normalisation of diurnal glucose concentrations by continuous administration of glucagon-like peptide-1 (GLP-1) in subjects with NIDDM.
by: Rachman, J, et al.
Published: (1997)

Glucagon like peptide-1 similarly amplifies insulin secretion in late-onset type 1 and type 2 diabetes
by: Maksoud, H, et al.
Published: (1999)

Glucagon-like peptide-1: regulation of insulin secretion and therapeutic potential.
by: Gromada, J, et al.
Published: (2004)

Perioperative insulin and glucose infusion maintains normal insulin sensitivity after surgery.
by: Nygren, J, et al.
Published: (1998)

Changes in amylin and amylin-like peptide concentrations and beta-cell function in response to sulfonylurea or insulin therapy in NIDDM.
by: Rachman, J, et al.
Published: (1998)

New insights into the regulation of glucagon secretion by glucagon-like peptide-1.
by: Gromada, J, et al.
Published: (2004)

Simple empirical assessment of beta-cell function by a constant infusion of glucose test in normal and type 2 (non-insulin-dependent) diabetic subjects.
by: Levy, J, et al.
Published: (1991)

CONTINUOUS INFUSION OF GLUCOSE FOR 53 HOURS IN NORMAL MAN DOES NOT IMPAIR B-CELL FUNCTION, BUT INCREASES INSULIN RESISTANCE
by: Flax, H, et al.
Published: (1989)

GLUCOSE-TOLERANCE AND BETA-CELL FUNCTION ASSESSED BY CONTINUOUS INFUSION OF GLUCOSE AND ORAL GLUCOSE-TOLERANCE TEST
by: Levy, J, et al.
Published: (1992)

NON-SULFONYLUREA A4166 STIMULATES INSULIN IN TYPE-2 DIABETES AND REDUCES POSTPRANDIAL GLUCOSE EXCURSION BY 64-PERCENT
by: Levy, J, et al.
Published: (1995)

GLUCOSE AND FREE FATTY-ACID TURNOVER AND ASSESSMENT OF INSULIN SENSITIVITY BY A CONSTANT INFUSION OF GLUCOSE TEST
by: Levy, J, et al.
Published: (1987)

Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes.
by: Hermans, M, et al.
Published: (1999)

Engineering an L-cell line that expresses insulin under the control of the glucagon-like peptide-1 promoter for diabetes treatment
by: Rasouli, Mina, et al.
Published: (2011)

Multisite regulation of insulin secretion by cAMP-increasing agonists: evidence that glucagon-like peptide 1 and glucagon act via distinct receptors.
by: Gromada, J, et al.
Published: (1997)

MECHANISM OF NON-ESTERIFIED FATTY-ACID SUPPRESSION DURING GLUCOSE INFUSIONS - IMPAIRMENT IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC SUBJECTS AND THEIR RELATIVES
by: Levy, J, et al.
Published: (1989)

Similar proportional, in spite of differing absolute responses to non-glucose and glucose insulin secretagogues in Type 2 diabetic, LADA and non-diabetic subjects
by: Meston, N, et al.
Published: (2007)

Calcium regulation of glucagon-like peptide-1 secretion.
by: Chua, Sharon Chia Ling.
Published: (2010)

Glucose in glucagon release.
by: Rorsman, P, et al.
Published: (1990)

Glucagon-like peptide 1 stimulates hypothalamic proopiomelanocortin neurons.
by: Ma, X, et al.
Published: (2007)

CYCLICAL VARIATION (HUNTING) OF BASAL PLASMA GLUCOSE AND INSULIN CONCENTRATIONS IN NORMAL AND DIABETIC MAN
by: Matthews, D, et al.
Published: (1978)

Glucose-insulin-potassium infusion in acute myocardial infarction.
by: Collins, R, et al.
Published: (1983)

Insulin infusion pump.
by: Holman, R, et al.
Published: (1981)

The insulin receptor talks to glucagon?
by: Gromada, J, et al.
Published: (2009)

Understanding "insulin resistance": both glucose resistance and insulin resistance are required to model human diabetes.
by: Rudenski, A, et al.
Published: (1991)

The effect of glibenclamide on insulin secretion at normal glucose concentrations
by: Riefflin, A, et al.
Published: (2014)

The effect of glibenclamide on insulin secretion at normal glucose concentrations.
by: Riefflin, A, et al.
Published: (2015)

ASSESSMENT OF B-CELL FUNCTION AND INSULIN RESISTANCE IN TYPE-II DIABETES BY CONTINUOUS INFUSION OF GLUCOSE WITH MODEL ASSESSMENT (CIGMA)
by: Turner, R, et al.
Published: (1985)

CONSTANT INFUSION OF GLUCOSE WITH MODEL ASSESSMENT AS A MEASURE OF INSULIN RESISTANCE IN MAN
by: Hosker, J, et al.
Published: (1983)

Normal proinsulin responses to glucose in mild type II subjects with subnormal insulin response.
by: Levy, J, et al.
Published: (1993)

Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis.
by: Armstrong, M, et al.
Published: (2015)

An unbiased glucose clamp method using a variable insulin infusion: its application in diabetic adolescents.
by: Matthews, DR, et al.
Published: (1990)

Comparison of in vivo tests for glucose tolerance in subjects with normal, impaired glucose tolerance and type 2 diabetes
by: Hermans, M, et al.
Published: (1996)

Desensitization of glucagon-like peptide 1 receptors in insulin-secreting beta TC3 cells: role of PKA-independent mechanisms.
by: Gromada, J, et al.
Published: (1996)

The beta cell glucose stimulus-response curve in normal humans assessed by insulin and C-peptide secretion rates.
by: Rudenski, A, et al.
Published: (1988)

Role of KATP channels in glucose-regulated glucagon secretion and impaired counterregulation in type 2 diabetes.
by: Zhang, Q, et al.
Published: (2013)

Role of synaptotagmin-7 in glucagon-like peptide (GLP-1) secretion.
by: Kang, Yvonne Yu Han.
Published: (2009)

Glucagon-like peptide I increases cytoplasmic calcium in insulin-secreting beta TC3-cells by enhancement of intracellular calcium mobilization.
by: Gromada, J, et al.
Published: (1995)

RESTING THE BETA-CELLS WITH INSULIN IN NIDDM DOES NOT IMPROVE BETA-CELL FUNCTION NOR PROINSULIN PROCESSING
by: Rachman, J, et al.
Published: (1995)

LOSS OF NORMAL SIGMOID, BETA-CELL DOSE-RESPONSE CURVE TO GLUCOSE IN NON-INSULIN-DEPENDENT DIABETES
by: Hosker, J, et al.
Published: (1984)